Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia [Phase 3]
Phase 3 trial evaluating TV-46000 as maintenance treatment in adults and adolescents with schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Transcranial Magnetic Stimulation for the Treatment of Auditory Hallucinations in Schizophrenia [NA]
Clinical trial update on transcranial magnetic stimulation for treating auditory hallucinations in schizophrenia; study terminated with resu…
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: ITI-007 (Lumateperone Tosylate) for Schizophrenia [Phase 2]
Phase 2 trial of ITI-007 (Lumateperone Tosylate) for schizophrenia has been terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: An Integrated Program for the Treatment of First Episode of Psychosis [NA]
Clinical trial update documenting completion of an integrated program for first-episode psychosis, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-22Clinical Trial Update: Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia [Phase 4]
Phase 4 trial evaluating a naltrexone and bupropion combination in obese, cigarette-smoking individuals with schizophrenia has completed wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-21Clinical Trial Update: Minocycline and Tobacco Craving in Smokers With Schizophrenia [Phase 4]
Phase 4 trial assessing minocycline for tobacco craving in smokers with schizophrenia; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY) [Phase 3]
Phase 3 clinical trial updating the burden of chronic psychotic disorders in Tanzania (CAPACITY) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: Pentoxifylline Add-on Therapy for Schizophrenia [Phase 1, Phase 2]
Clinical trial update describes pentoxifylline as add-on therapy for schizophrenia in Phase 1 and Phase 2 studies.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder [Phase 2]
Phase 2 study of ALKS 3831 in adults with schizophrenia and alcohol use disorder has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder [Phase 3]
Phase 3 clinical trial evaluating raloxifene augmentation in patients with schizophrenia-spectrum disorders has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: Study of the Effect of Dosing on Clozapine Levels [Phase 4]
Phase 4 trial investigating how dosing impacts clozapine levels was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Adapting Critical Time Intervention to Support Inpatient Medical Care Transition [NA]
A clinical trial update on adapting Critical Time Intervention to support inpatient medical care transitions, with termination as the status…
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia [Phase 2]
Phase 2 study evaluating the efficacy and safety of SEP-363856 in acutely psychotic adults with schizophrenia has completed and posted resul…
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms [Phase 2]
Phase 2 clinical trial update for LY2140023 in schizophrenia patients with prominent negative symptoms has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: A Physical Dependence Study in Schizophrenia [Phase 3]
Phase 3 clinical trial evaluating physical dependence in schizophrenia; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: A Study in Schizophrenic Patients [Phase 2]
Phase 2 clinical trial in schizophrenia was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: A Study of Safety and Tolerability in Subjects With Schizophrenia [Phase 1]
Phase 1 trial assessing safety and tolerability in subjects with schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults [Phase 2, Phase 3]
Adaptive Phase II/III study evaluating NaBen as add-on therapy to clozapine for residual symptoms in adults with refractory schizophrenia; c…
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction [NA]
Clinical trial assessing the relationship between cognitive function and relapse in schizophrenia when dose is reduced; results posted after…
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: A Study of ALKS 3831 in Adults With Schizophrenia [Phase 2]
Phase 2 trial update for ALKS 3831 in adults with schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite® [Phase 3]
Phase 3 trial examining Abilify MyCite in adults with schizophrenia was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: Tryptophan MRI in People With Schizophrenia and Healthy Controls [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating tryptophan MRI in people with schizophrenia and healthy controls has completed, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: Study of LY2140023 in Schizophrenia Comparing LY2140023, Olanzapine, and Placebo [Phase 2]
Phase 2 trial comparing LY2140023, olanzapine, and placebo in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia. [Phase 2]
Phase 2 trial update for pharmacologically-augmented cognitive therapies (PACTs) in schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia [Phase 3]
Phase 3 trial update examining whether adding ondansetron to ongoing antipsychotic therapy improves outcomes in schizophrenia; study complet…